Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > market depth

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Feb 02, 2021 7:58am

84 Views

Post# 32444871

market depth

V:VXL Depth by Order @07:57:32

Bid			Ask
Broker	Size	Price	Price	Size	Broker
85 Scotia	12,800	0.47	0.47	21,000	7 TD Sec
79 CIBC	3,000	0.47	0.48	4,500	79 CIBC
57 Interactive	580	0.47	0.49	40,000	9 BMO Nesbitt
7 TD Sec	1,000	0.47	0.49	16,500	7 TD Sec
7 TD Sec	2,000	0.47	0.495	8,911	7 TD Sec
7 TD Sec	1,000	0.47	0.50	500	7 TD Sec
124 Questrade	2,000	0.47	0.50	2,000	85 Scotia
2 RBC	2,000	0.47	0.50	20,000	7 TD Sec
2 RBC	2,000	0.47	0.50	20,000	7 TD Sec
19 Desjardins	1,500	0.47	0.50	10,000	7 TD Sec